Suppr超能文献

比较用于检测体液和组织中巨细胞病毒 DNA 的自动化核酸提取方法。

Comparison of automated nucleic acid extraction methods for the detection of cytomegalovirus DNA in fluids and tissues.

机构信息

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine , Stanford, CA , USA.

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine , Stanford, CA , USA ; Department of Pathology, Stanford University School of Medicine , Stanford, CA , USA.

出版信息

PeerJ. 2014 Apr 8;2:e334. doi: 10.7717/peerj.334. eCollection 2014.

Abstract

Testing for cytomegalovirus (CMV) DNA is increasingly being used for specimen types other than plasma or whole blood. However, few studies have investigated the performance of different nucleic acid extraction protocols in such specimens. In this study, CMV extraction using the Cell-free 1000 and Pathogen Complex 400 protocols on the QIAsymphony Sample Processing (SP) system were compared using bronchoalveolar lavage fluid (BAL), tissue samples, and urine. The QIAsymphonyAssay Set-up (AS) system was used to assemble reactions using artus CMV PCR reagents and amplification was carried out on the Rotor-Gene Q. Samples from 93 patients previously tested for CMV DNA and negative samples spiked with CMV AD-169 were used to evaluate assay performance. The Pathogen Complex 400 protocol yielded the following results: BAL, sensitivity 100% (33/33), specificity 87% (20/23); tissue, sensitivity 100% (25/25), specificity 100% (20/20); urine, sensitivity 100% (21/21), specificity 100% (20/20). Cell-free 1000 extraction gave comparable results for BAL and tissue, however, for urine, the sensitivity was 86% (18/21) and specimen quantitation was inaccurate. Comparative studies of different extraction protocols and DNA detection methods in body fluids and tissues are needed, as assays optimized for blood or plasma will not necessarily perform well on other specimen types.

摘要

越来越多的人开始使用除血浆或全血以外的标本类型来检测巨细胞病毒(CMV)DNA。然而,很少有研究调查不同核酸提取方案在这些标本中的性能。在这项研究中,使用 QIAsymphony SP 系统上的 Cell-free 1000 和 Pathogen Complex 400 方案从支气管肺泡灌洗液(BAL)、组织样本和尿液中提取 CMV。QIAsymphony AS 系统用于使用 artus CMV PCR 试剂组装反应,在 Rotor-Gene Q 上进行扩增。使用 93 例先前检测过 CMV DNA 且用 CMV AD-169 污染的阴性样本评估检测性能。Pathogen Complex 400 方案的结果如下:BAL,敏感性 100%(33/33),特异性 87%(20/23);组织,敏感性 100%(25/25),特异性 100%(20/20);尿液,敏感性 100%(21/21),特异性 100%(20/20)。Cell-free 1000 提取在 BAL 和组织中得到了可比的结果,但在尿液中,敏感性为 86%(18/21),标本定量不准确。需要对不同的体液和组织提取方案和 DNA 检测方法进行比较研究,因为针对血液或血浆优化的检测方法在其他标本类型上不一定能很好地发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7078/3994632/fe7826bc94c0/peerj-02-334-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验